{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:57:40Z","timestamp":1787320660862,"version":"build-2736575974"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T00:00:00Z","timestamp":1670976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>One of the most important complications of obesity is insulin resistance, which leads to carbohydrate metabolism disorders such as type 2 diabetes. However, obesity is also associated with development of an autoimmune response against various organs, including pancreatic beta cells. The prevalence of such autoimmune processes in children and their possible contribution to the increased incidence of type 1 diabetes is currently unclear. Therefore, the present study assessed the prevalence of autoantibodies against pancreatic islet beta cell\u2019s antigens in children and adolescents with simple obesity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Material and methods<\/jats:title>\n                    <jats:p>This prospective observational study included pediatric patients (up to 18 years of age) with simple obesity hospitalized between 2011 and 2016 at the Department of Pediatrics, Diabetology, Endocrinology and Nephrology of the Medical University of Lodz. Children with acute or chronic conditions that might additionally affect insulin resistance or glucose metabolism were excluded. Collected clinical data included sex, age, sexual maturity ratings (Tanner`s scale), body height and weight, waist and hip circumference, amount of body fat and lean body mass. Each participant underwent a 2-hour oral glucose tolerance test with simultaneous measurements of glycaemia and insulinemia at 0`, 60` and 120`. In addition, glycated hemoglobin HbA1c, fasting and stimulated c-peptide, total cholesterol, as well as high- and low-density cholesterol and triglycerides were measured. Insulin resistance was assessed by calculating HOMA-IR index. The following autoantibodies against pancreatic islet beta cells were determined in each child: ICA - antibodies against cytoplasmic antigens of pancreatic islets, GAD - antibodies against glutamic acid decarboxylase, ZnT8 - antibodies against zinc transporter, IA2 - antibodies against tyrosine phosphatase, IAA \u2013 antibodies against insulin.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The study group included 161 children (57.4% boys, mean age 13.1 \u00b1 2.9 years) with simple obesity (mean BMI z-score +2.2 \u00b1 1.6). Among them, 28 (17.4%) were diagnosed with impaired glucose metabolism during OGTT [23 (82.2%) \u2013 isolated impaired glucose tolerance (IGT), 3 (10.7%) \u2013 isolated impaired fasting glucose (IFG), 2 (7.1%) \u2013 IFG and IGT]. Of the children tested, 28 (17.4%) were tested positive for at least one islet-specific autoantibody [with similar percentages in boys (15, 17.4%) and girls (13, 17.3%), p=0.9855], with ICA being the most common (positive in 18, 11.2%), followed by IAA (7, 4.3%), ZnT8 (5, 3.1%), GADA (3, 1.9%) and IA2 (1, 0.6%). There was no association between the presence of the tested antibodies and age, sex, stage of puberty, parameters assessing the degree of obesity, HbA1c, lipid levels and basal metabolic rate. However, autoantibody-positive subjects were more likely to present IFG or IGT in OGTT compared to those who tested completely negative (9, 32.1% vs 19, 14.3%, p=0.0280). Their HOMA-IR was also significantly higher (HOMA-IR: 4.3 \u00b1 1.9 vs 3.4 \u00b1 1.9, p=0.0203) and this difference remained statistically significant after adjusting for sex and age (p=0.0340).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Children and adolescents with simple obesity presented a higher prevalence of markers of autoimmune response against pancreatic beta cells than the general population. Most often, they had only one type of antibody - ICA. The presence of autoimmune response indicators against pancreatic islet antigens is more common in obese patients with impaired carbohydrate metabolism and is associated with lower insulin sensitivity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2022.1061671","type":"journal-article","created":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T01:30:00Z","timestamp":1670981400000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Autoimmune reaction against pancreatic beta cells in children and adolescents with simple obesity"],"prefix":"10.3389","volume":"13","author":[{"given":"Aneta","family":"Chyli\u0144ska-Fr\u0105tczak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwona","family":"Pietrzak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arkadiusz","family":"Michalak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystyna","family":"Wyka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Szadkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,14]]},"reference":[{"key":"B1","unstructured":"Obesity and overweight"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60460-8","article-title":"(The GBD 2013 obesity collaboration) global, regional and national prevalence of overweight and obesity in children and adults 1980-2013: A systematic analysis lancet","volume":"384","author":"Ng","year":"2014","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-015-1382-6","article-title":"The dangerous link between childhood and adulthood predictors of obesity and metabolic syndrome","volume":"11","author":"Faienza","year":"2016","journal-title":"Intern Emerg Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003078","article-title":"Association of childhood obesity with risk of early all-cause and cause-specific mortality: A Swedish prospective cohort study","volume":"17","author":"Lindberg","year":"2020","journal-title":"PloS Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-020-05358-3","article-title":"TRIGR investigators growth and development of islet autoimmunity and type 1 diabetes in children genetically at risk","volume":"64","author":"Nucci","year":"2021","journal-title":"Diabetologia"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.923744","article-title":"Disparities in the prevalence of childhood obesity-related comorbidities: A systematic review front public health","volume":"10","author":"Obita","year":"2022","journal-title":"Front Public Health"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62219-9","article-title":"The many faces of diabetes: a disease with increasing heterogeneity","volume":"383","author":"Tuomi","year":"2014","journal-title":"Lancet"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1177\/2040622314548679","article-title":"Early onset type 2 diabetes: risk factors, clinical impact and management","volume":"5","author":"Wilmot","year":"2014","journal-title":"Ther Adv Chronic Dis"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-012-2719-6","article-title":"Clinical evolution of beta cell function in youth with diabetes: the SEARCH for diabetes in youth study","volume":"55","author":"Dabelea","year":"2012","journal-title":"Diabetologia"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.12939","article-title":"The changing face of diabetes in youth: lessons learned from studies of type 2 diabetes","volume":"1353","author":"Hannon","year":"2015","journal-title":"Ann N Y Acad Sci"},{"key":"B11","article-title":"Autoantibodies in children with type 2 diabetes mellitus","author":"Umpaichitra","year":"2002","journal-title":"J Pediatr Endocrinol Metab"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2005.088229","article-title":"Beta-cell autoantibodies in children with type 2 diabetes mellitus: subgroup or misclassification","volume":"91","author":"Reinehr","year":"2006","journal-title":"Arch Dis Child"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s001250100548","article-title":"The accelerator hypothesis: weight gain as the missing link between type I and type II diabetes","volume":"44","author":"Wilkin","year":"2001","journal-title":"Diabetologia"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1007\/s00125-005-0033-2","article-title":"The a\u2019ccelerator hypothesis\u2019: relationship between weight, height, body mass index and age at diagnosis in a large cohort of 9,248 German and Austrian children with type 1 diabetes mellitus","volume":"48","author":"Knerr","year":"2005","journal-title":"Diabetologia"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s13679-020-00397-8","article-title":"Autoantibody production in obesity: Is there evidence for a link between obesity and autoimmunity","volume":"9","author":"Tsigalou","year":"2020","journal-title":"Curr Obes Rep"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-009-1428-2","article-title":"Height growth velocity, islet autoimmunity and type 1 diabetes development: the diabetes autoimmunity study in the young diabetologia","volume":"52","author":"Lamb","year":"2009","journal-title":"Diabetologia"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2010.03160.x","article-title":"Association between childhood obesity and subsequent type 1 diabetes: A systematic review and meta-analysis","volume":"28","author":"Verbeeten","year":"2011","journal-title":"Diabetes Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.2337\/db15-1180","article-title":"Growth and risk for islet autoimmunity and progression to type 1 diabetes in early childhood: The environmental determinants of diabetes in the young study","volume":"65","author":"Larsson","year":"2016","journal-title":"Diabetes"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-1167","article-title":"Type 1 diabetes TrialNet study group excess BMI accelerates islet autoimmunity in older children and adolescents","volume":"43","author":"Ferrara-Cook","year":"2020","journal-title":"Diabetes Care"},{"key":"B20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/pedi.12773","article-title":"ISPAD clinical practice consensus guidelines 2018: Definition, epidemiology, diagnosis and classification of diabetes in children and adolescents","author":"Mayer-Davis","year":"2018","journal-title":"Pediatr Diabetes"},{"key":"B21","article-title":"Percentile charts for growth and nutritional status assessment in polish children and adolescents from birth to 18 year of age standardy Medyczne\/Pediatria","volume":"12","author":"Ku\u0142aga","year":"2015","journal-title":"Standardy Medyczne\/Pediatria"},{"key":"B22","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s00428-021-03055-z","article-title":"Insulitis in the pancreas of non-diabetic organ donors under age 25 years with multiple circulating autoantibodies against islet cell antigens","volume":"479","author":"Smeets","year":"2021","journal-title":"Virchows Arch"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-015-0751-y","article-title":"Prediction of type 1 diabetes in sardinian schoolchildren using islet cell autoantibodies: 10-year follow-up of the sardinian schoolchildren type 1 diabetes prediction study","volume":"53","author":"Velluzzi","year":"2016","journal-title":"Acta Diabetol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/dmrr.554","article-title":"Developments in the prediction of type 1 diabetes mellitus, with special reference to insulin autoantibodies","volume":"2","author":"Franke","year":"2005","journal-title":"Diabetes Metab Res Rev"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.815703","article-title":"The prevalence of islet autoantibodies in children and adolescents with type 1 diabetes mellitus: A global scoping review","volume":"13","author":"Ross","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B26","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s00125-005-1690-x","article-title":"Islet autoantibodies in clinically diagnosed type 2 diabetes: prevalence and relationship with metabolic control (UKPDS 70)","volume":"48","author":"Davis","year":"2005","journal-title":"Diabetologia"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.53.12.3193","article-title":"Phenotypic characteristics of GAD antibody-positive recently diagnosed patients with type 2 diabetes in north America and Europe","volume":"53","author":"Zinman","year":"2004","journal-title":"Diabetes"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3109\/08916934.2011.604658","article-title":"Detection and characterization of ZnT8 autoantibodies could help to screen latent autoimmune diabetes in adult-onset patients with type 2 phenotype","volume":"45","author":"Trabucchi","year":"2012","journal-title":"Autoimmunity"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1080\/08916934.2018.1547711","article-title":"Islet autoantibody positivity in overweight and obese adults with type 2","volume":"51","author":"Pilla","year":"2018","journal-title":"Diabetes Autoimmun"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2005.088229","article-title":"\u03b2-cell autoantibodies in children with type 2 diabetes mellitus: subgroup or misclassification","volume":"91","author":"Reinehr","year":"2006","journal-title":"Arch Dis Child"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.23750\/abm.v89iS4.7359","article-title":"Prevalence of \u03b2-cell antibodies and associated autoimmune diseases in children and adolescents with type 1 diabetes (T1DM) versus type 2 diabetes (T2DM) in Qatar","volume":"89","author":"Alyafei","year":"2018","journal-title":"Acta BioMed"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.2337\/db08-1372","article-title":"Phenotypic type 2 diabetes in obese youth: secretion in islet cell antibody-negative versus -positive patients","volume":"58","author":"Tfayli","year":"2009","journal-title":"Diabetes"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.12249","article-title":"Obesity and youth diabetes: Distinguishing characteristics between islet cell antibody positive vs. negative patients over time","volume":"16","author":"Rivera-Vega","year":"2015","journal-title":"Pediatr Diabetes"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-1573","article-title":"Prevalence of type 1 diabetes autoantibodies (GADA, IA2, and IAA) in overweight and obese children","volume":"33","author":"Cambuli","year":"2010","journal-title":"Diabetes Care"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.12093","article-title":"Islet cell antibodies (ICA) identify autoimmunity in children with new onset diabetes mellitus negative for other islet cell antibodies","volume":"15","author":"Andersson","year":"2014","journal-title":"Pediatr Diabetes"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa624","article-title":"Dynamics of islet autoantibodies during prospective follow-up from birth to age 15 years","volume":"105","author":"P\u00f6ll\u00e4nen","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B37","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/cel.13360","article-title":"Birth and coming of age of islet autoantibodies","volume":"198","author":"Bonifacio","year":"2019","journal-title":"Clin Exp Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.6285","article-title":"Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children","volume":"309","author":"Ziegler","year":"2013","journal-title":"JAMA"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-1419","article-title":"Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the endocrine society, and the American diabetes association","volume":"38","author":"Insel","year":"2015","journal-title":"Diabetes Care"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.2174\/1573399814666180608074510","article-title":"Pathophysiology of type 2 diabetes in children and adolescents","volume":"16","author":"Valaiyapathi","year":"2020","journal-title":"Curr Diabetes Rev"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-2183","article-title":"Glucose effectiveness in obese children: Relation to degree of obesity and dysglycemia","volume":"38","author":"Weiss","year":"2015","journal-title":"Diabetes Care"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/ijo.2013.124","article-title":"Impaired fasting glucose prevalence in two nationwide cohorts of obese children and adolescents","volume":"38","author":"Hagman","year":"2014","journal-title":"Int J Obes (Lond)"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/ijpo.12601","article-title":"Prevalence of prediabetes and type 2 diabetes in children with obesity and increased transaminases in European German-speaking countries","volume":"15","author":"Koutny","year":"2020","journal-title":"Anal APV initiative Pediatr Obes"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-4642(18)30235-9","article-title":"Trajectories of changes in glucose tolerance in a multiethnic cohort of obese youths: an observational prospective analysis","volume":"2","author":"Galderisi","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"key":"B45","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12933-017-0528-4","article-title":"Regulation of visceral and epicardial adipose tissue for preventing cardiovascular injuries associated to obesity and diabetes","volume":"16","author":"Gonz\u00e1lez","year":"2017","journal-title":"Cardiovasc Diabetol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-1376","article-title":"Adipose insulin resistance in obese adolescents across the spectrum of glucose tolerance","volume":"101","author":"Hershkop","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B47","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.autrev.2014.07.001","article-title":"Obesity in autoimmune diseases: not a passive bystander","volume":"13","author":"Versini","year":"2014","journal-title":"Autoimmun Rev"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e3055","DOI":"10.1002\/dmrr.3055","article-title":"Evidence of diabetes-specific autoimmunity in obese subjects with normal glucose tolerance","author":"Tiberti","year":"2018","journal-title":"Diabetes Metab Res Rev"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-0475","article-title":"Setting the stage for islet autoimmunity in type 2 diabetes: Obesity-associated chronic systemic inflammation and endoplasmic reticulum (ER) stress","volume":"42","author":"Brooks-Worrell","year":"2019","journal-title":"Diabetes Care"},{"key":"B50","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/pedi.12719","article-title":"ISPAD clinical practice consensus guidelines 2018 type 2 diabetes mellitus in youth","author":"Zeitler","year":"2018","journal-title":"Pediatr Diabetes"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-1642","article-title":"Characteristics of adolescents and youth with recent-onset type 2 diabetes: the TODAY cohort at baseline","volume":"96","author":"Copeland","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2009.02.016","article-title":"The pancreatic beta-cell as a target of estrogens and xenoestrogens: Implications for blood glucose homeostasis and diabetes","volume":"304","author":"Nadal","year":"2009","journal-title":"Mol Cell Endocrinol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(19)30412-7","article-title":"Type 1 diabetes\u2013early life origins and changing epidemiology","volume":"8","author":"Norris","year":"2020","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1061671\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T01:30:07Z","timestamp":1670981407000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1061671\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,14]]},"references-count":53,"alternative-id":["10.3389\/fendo.2022.1061671"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.1061671","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,14]]},"article-number":"1061671"}}